Last update:

Parkinson's & Movement disorders news

Parkinson's & Movement disorders

Researchers: Exercise should be prescribed for people with Parkinson's

No pharmacological medication currently available can cure or slow down Parkinson's disease. However, based on an extensive literature review recently published in the journal Journal of Neurology, Neurosurgery & Psychiatry, ...

Parkinson's & Movement disorders

Study identifies genetic link between inflammatory bowel disease and Parkinson's disease

Researchers at the Icahn School of Medicine at Mount Sinai have made a significant discovery, identifying genetic connections between inflammatory bowel disease (IBD) and Parkinson's disease (PD). Published in Genome Medicine ...

Parkinson's & Movement disorders

Recognizing symptoms of Parkinson's disease

April is Parkinson's Disease Awareness Month, which make this a good time to learn about the symptoms of Parkinson's disease.

Parkinson's & Movement disorders

Improving prospects for people with Parkinson's

In an evolving journey toward understanding and supporting those living with Parkinson's disease, a new report offers fresh insights into the burden it places on those affected.

Parkinson's & Movement disorders

Novel test holds promise for detecting Parkinson's disease early

In the development of Parkinson's disease (PD), the changes that will lead to neurodegeneration take place in the brain long before patients show any symptoms. But without a test that can detect these changes, it's difficult ...

Parkinson's & Movement disorders

New evidence suggests link between gut health and Parkinson's disease

While previous studies suggest Parkinson's disease begins in the gut and spreads to the brain, how the process occurs has been elusive. Now, a pre-clinical study led by Duke Health researchers provides new evidence that bolsters ...

Neuroscience

Unlocking the secrets of the brain's dopaminergic system

A new organoid model of the dopaminergic system sheds lights on its intricate functionality and potential implications for Parkinson's disease. The model, developed by the group of Jürgen Knoblich at the Institute of Molecular ...